YD Bio Limited Ordinary S... (YDES)
NASDAQ: YDES
· Real-Time Price · USD
17.11
-3.95 (-18.76%)
At close: Sep 24, 2025, 3:59 PM
17.46
2.05%
After-hours: Sep 24, 2025, 07:35 PM EDT
Company Description
Breeze Holdings Acquisition Corp. operates as a clinical-stage biopharmaceutical company focuses on cancer prevention medical diagnostics and the development of exosome-based therapeutics with the potential to transform the treatment of a diseases with unmet medical need.
The company is based in Taipei, Taiwan.
YD Bio Limited Ordinary Shares
| Country | KY |
| IPO Date | Aug 29, 2025 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | n/a |
| CEO | Ethan Shen |
Contact Details
Address: No Address available No city data available, KY | |
| Website | n/a |
Stock Details
| Ticker Symbol | YDES |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | KYG983011076 |
| Employer ID | - |
| SIC Code | n/a |